← Back to Search

Behavioural Intervention

SMS Intervention for ADHD

N/A
Waitlist Available
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if sending personalized text messages can help adults with ADHD remember to take their medication and manage their condition better. Participants will receive regular text messages reminding them about their medication schedule and providing educational tips about ADHD. The goal is to see if these reminders improve how well patients stick to their treatment plan.

Eligible Conditions
  • Attention Deficit Hyperactivity Disorder (ADHD)

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adherence to Stimulants

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: SMS InterventionExperimental Treatment1 Intervention
All subjects will receive customized text messages twice a day, every day for 9 months that will include reminders to adhere to the individualized medication regimen, reminders to call their clinician for a prescription refill followed by reminders to pick up medication from the pharmacy, and educational reminders about ADHD and its treatment.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
3,012 Previous Clinical Trials
13,309,154 Total Patients Enrolled
59 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
8,400 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Shire Human Genetic Therapies, Inc.Industry Sponsor
5 Previous Clinical Trials
5,210 Total Patients Enrolled

Media Library

SMS Intervention (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04189575 — N/A
Attention Deficit Hyperactivity Disorder (ADHD) Research Study Groups: SMS Intervention
Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trial 2023: SMS Intervention Highlights & Side Effects. Trial Name: NCT04189575 — N/A
SMS Intervention (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04189575 — N/A
Attention Deficit Hyperactivity Disorder (ADHD) Patient Testimony for trial: Trial Name: NCT04189575 — N/A
~16 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top